Clinical and radiographic outcomes of rheumatoid arthritis patients not treated with disease-modifying drugs

Arthritis and Rheumatism

Volumn 41, Issue 7, 1998, Pages 1190-1195

  Abu Shakra, Mahmoud ^a,c   Toker, Rita ^a   Flusser, Daniel ^a   Flusser, Gideon ^b   Friger, Michael ^a   Sukenik, Shaul ^a   Buskila, Dan ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b Ichelov Medical Center   (Israel)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; AZATHIOPRINE; CHLOROQUINE; CYCLOSPORIN A; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; SALAZOSULFAPYRIDINE;

ADULT; ARTHROPATHY; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; HUMAN; ISRAEL; JEW; JOINT RADIOGRAPHY; LONG TERM CARE; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RUSSIAN FEDERATION; SYNOVITIS;

ADULT; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE);

EID: 0031810393     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199807)41:7<1190::AID-ART7>3.0.CO;2-B     Document Type: Article

References (29)

1. Weinblatt ME, Trentham DE, Fraser PA, Holdsworth DE, Falchuk KR, Weissman BN, et al. Long-term prospective trial of low-dose methotrexate in rheumatoid arthritis. Arthritis Rheum 1988;31:167-75.
2. Kremer JM, Lee JK. A long-term prospective study of the use of methotrexate in rheumatoid arthritis: update after a mean of fifty-three months. Arthritis Rheum 1988;31:577-84.
3. Van der Heide A, Jacobs JW, Bijisma JW, Heurkens AH, van Booma-Frankfort C, van der Veen MJ. The effectiveness of early treatment with "second-line" antirheumatic drugs: a randomized, controlled trial. Ann Intern Med 1996;124:699-707.
4. Alarcón GS, Lopez-Mendez A, Walter J, Boerbooms AM, Russell AS, Furst DE, et al. Radiographic evidence of disease progression in methotrexate treated and nonmethotrexate disease modifying antirheumatic drug treated rheumatoid arthritis patients: a meta-analysis. J Rheumatol 1992;19:1868-73.
5. Førre Ø, and the Norwegian Arthritis Study Group. Radiologic evidence of disease modification in rheumatoid arthritis patients treated with cyclosporine: results of a 48-week multicenter study comparing low-dose cyclosporine with placebo. Arthritis Rheum 1994;37:1506-12.
6. Jeurissen MEC, Boerbooms AM, van de Putte LBA, Doesburg WH, Lemmens AM. Influence of methotrexate and azathioprine on radiologie progression in rheumatoid arthritis. Ann Intern Med 1991;114:999-1004.
7. Pullar T, Hunter JA, Capell HA. Effect of sulphasalazine on the radiological progression of rheumatoid arthritis. Ann Rheum Dis 1987;46:398-402.
8. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
9. Gordon DA, Keystone EC, Smythe HA. Diagnosis and assessment. In: Rheumatoid arthritis. Medical Examination Publishing Co.; 1985.
10. Kalinkhoff AV, Bellamy N, Bombardier C. An experiment in reducing inter observer variability of the examination for joint tenderness. J Rheumatol 1988;15:492-4.
11. Hochberg MC, Chang RW, Dwosh I, Lindsey S, Pincus T, Wolfe F. The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis. Arthritis Rheum 1992;35:498-502.
12. Steinbrocker O, Traeger CH, Batterman RC. Therapeutic criteria in rheumatoid arthritis. JAMA 1949;140:659-62.
13. Sharp JT, Young DY, Bluhm GB, Brook A, Brower AC, Corbett M, et al. How many joints in the hands and wrists should be included in a score of radiologie abnormalities used to assess rheumatoid arthritis? Arthritis Rheum 1985;28:1326-35.
14. Hanly JG, Russell ML, Gladman DD. Psoriatic spondyloarthropathy: a long term prospective study. Ann Rheum Dis 1988;47: 386-93.
15. Scott DL, Symmons DP, Coulton BL, Popert AJ. Long-term outcome of treating rheumatoid arthritis: results after 20 years. Lancet 1987;16:1108-11.
16. Wolfe F, Mitchell DM, Sibley JT, Fries JF, Bloch DA, Williams CA, et al. The mortality of rheumatoid arthritis. Arthritis Rheum 1994;37:481-94.
17. Wilske KR, Healey LA. Remodeling the pyramid - a concept whose time has come. J Rheumatol 1989;16:565-7.
18. Pincus T, Callahan LF. Remodeling the pyramid or remodeling the paradigms concerning rheumatoid arthritis - lessons from Hodgkin's disease and coronary artery disease. J Rheumatol 1990;17:1582-5.
19. Fries JF. Reevaluating the therapeutic approach to rheumatoid arthritis: the sawtooth strategy. J Rheumatol 1990;22:12-5.
20. lannuzzi L, Dawson N, Zein N, Kushner I. Does drug therapy slow radiographic deterioration in rheumatoid arthritis? N Engl J Med 1983;309:1023-8.
21. Van Riel PL, van der Heijde DM, Nuver-Zwart IH, van de Putte LB. Radiographic progression in rheumatoid arthritis: results of 3 comparative trials. J Rheumatol 1995;22:1797-9.
22. Van der Heijde DM, van Leeuwen MA, van Riel PL, van de Putte LB. Radiographic progression on radiographs of hands and feet during the first 3 years of rheumatoid arthritis measured according to Sharp's method (van der Heijde modification). J Rheumatol 1995;22:1792-6.
23. Van der Heijde DMFM, van Leeuwen MA, van Riel PLCM, Koster AM, van 't Hof MA, van Rijswijk MH, et al. Biannual radiographic assessments of hands and feet in a three-year prospective followup of patients with early rheumatoid arthritis. Arthritis Rheum 1992;35:26-34.
24. Wolfe F, Hawley DJ, Cathey MA. Termination of slow acting anti-rheumatic therapy in RA: a 14-year prospective evaluation of 1017 consecutive starts. J Rheumatol 1990;17:994-1002.
25. Pincus T, Marcum SB, Callahan LF. Longterm drug therapy for rheumatoid arthritis in seven rheumatology private practices. II. Second line drugs and prednisone. J Rheumatol 1992;19:1885-94.
26. Pincus T, Stein CM. What is the best source of useful data on the treatment of RA: clinical trials, clinical observations, or clinical protocol? J Rheumatol 1995;22:1611-7.
27. Pincus T, Stein CM. Why randomized controlled clinical trials do not depict accurately long term outcomes in rheumatoid arthritis: some explanations and suggestions for future studies. Clin Exp Rheumatol 1997;15:S27-38.
28. Pincus T, Callahan LF. Prognostic markers of activity and damage in rheumatoid arthritis: why clinical trials and inception cohort studies indicate more favourable outcomes than studies of patients with established disease. Br J Rheumatol 1995;34:196-9.
29. Hawley DJ, Wolfe F. Sensitivity to change of the Health Assessment Questionnaire and other clinical and health status measures in rheumatoid arthritis: results of short-term clinical trials and observational studies versus long-term observational studies. Arthritis Care Res 1992;5:130-6.